Literature DB >> 9257413

Frailty modelling for the excess hazard.

P H Zahl1.   

Abstract

Long-term excess hazards for cancer survival sometimes tend to zero or become negative even though we expect them to be positive. This may be explained by selection at diagnosis; individuals with certain cancers may have an increased risk of dying of other diseases in general. Then comparing with population mortality rates is not correct. Alternatively, we may have a continuous selection of the most robust individuals after diagnosis. When there are unobserved heterogeneity, and those with highest risk of dying of cancer also have the highest risk of dying of other diseases, this will cause selection after diagnosis. This may be modelled by multivariate frailty variables, and a corrected excess hazard may be estimated. In two examples, these corrected excess hazards give a better estimate when comparing to the cause-specific cancer mortality. Actually, this study questions the usefulness of long-term excess hazard rates.

Entities:  

Mesh:

Year:  1997        PMID: 9257413     DOI: 10.1002/(sici)1097-0258(19970730)16:14<1573::aid-sim585>3.0.co;2-q

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Adjusting and comparing survival curves by means of an additive risk model.

Authors:  P H Zahl; O O Aalen
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

2.  Robust age at onset linkage analysis in nuclear families.

Authors:  Andrea Callegaro; J C van Houwelingen; J J Houwing-Duistermaat
Journal:  Hum Hered       Date:  2009-12-04       Impact factor: 0.444

3.  Unobserved heterogeneity can confound the effect of education on mortality.

Authors:  Anna Zajacova; Noreen Goldman; Germán Rodríguez
Journal:  Math Popul Stud       Date:  2009-04-10       Impact factor: 0.720

4.  Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.

Authors:  Pieter H M van Baal; Rudolf T Hoogenveen; G Ardine de Wit; Hendriek C Boshuizen
Journal:  Popul Health Metr       Date:  2006-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.